glp 1 economist A second helping of weight-loss drugs is coming The unknown trajectory of GLP-1

Evaluate the benefits and concerns surrounding GLP-1 treatments

Shop music, movies, toys & games, too

The FDA flagged marketing claims suggesting that compounded GLP-1s shared the same safety and efficacy profiles as their branded counterparts, noting that such labeling can mislead consumers and violate the Food, Drug, and Cosmetic Act

We're proud to already support thousands of patients using medications like Ozempic, Mounjaro, and Zepbound

Starting at $149 monthly, these medications provide the same active ingredient with pharmacist-guided precision do

For a $50 copay, Medicares new GLP-1 Bridge puts a medicine I used to prescribe knowing the coverage would never follow within reach.